Patents
Patents for C07D 471 - Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups (64,559)
09/2013
09/03/2013US8524899 Alternative heterocycles for DNA recognition
09/03/2013US8524722 Substituted tricyclic compounds and methods of use thereof
09/03/2013US8524720 Substituted N-(pyrazol-5-yl)-pyrrolo[3,2-D]pyrimidin-4-amine useful as protein kinase inhibitors
09/03/2013US8524712 Triazinone and diazinone derivatives useful as HSP90 inhibitors
09/03/2013US8524711 Amino-derivatives as novel inhibitors of histone deacetylase
09/03/2013US8524704 Azepinoindole derivatives as pharmaceutical agents
09/03/2013US8524703 Bridgehead amine ring-fused indoles and indolines
09/03/2013CA2596754C Crystalline 1h-imidazo[4,5-b]pyridin-5-amine,7-[5-[(cyclohexylmethylamino)-methyl]-1h-indol-2-yl]-2-methyl, sulfate (1:1), trihydrate and its uses for the treatment of inflammatory, autoimmune and proliferative diseases and disorders
09/03/2013CA2558211C Bicyclic and bridged nitrogen heterocycles
09/03/2013CA2522562C 2-phenyl-benzimidazol and 2-phenyl-imidazo-`4,5!-pyridine derivatives as checkpoint kinase cds1 (chk2) inhibitors for the treatment of cancer
08/2013
08/29/2013WO2013126656A1 Pyridopyrimidinone inhibitors of kinases
08/29/2013WO2013124341A1 Substituted pyrazolo[1,5-a]pyridines, their preparation and use as medicaments
08/29/2013US20130225813 PROCESS FOR MAKING (R) -3-(2,3-DIHYDROXYPROPYL)-6-FLUORO-5-(2-FLOURO-4-IODOPHENYLAMINO)-8-METHYLPYRIDO[2,3-d]PYRIMIDINE-4,7(3H,8H)-DIONE AND INTERMEDIATES THEREOF
08/29/2013US20130225636 N-(5s,6s,9r)-5-amino-6-(2,3-difluorophenyl)-6,7,8,9-tetrahydro-5h-cyclohepta[b]pyridin-9-yl-4-(2-oxo-2,3-dihydro-1h-imidazo[4,5-b]pyridin-1-yl)piperidine-1-carboxylate salt
08/29/2013US20130225635 Fused bicyclic diamine derivatives as hiv attachment inhibitors
08/29/2013US20130225633 Phenyl heterocycloalkyl glucocorticoid receptor modulators
08/29/2013US20130225632 Calcium salt of pyrroloquinoline quinone
08/29/2013US20130225616 Crystalline form of pyrimidio[6,1-a] isoquinolin-4-one compound
08/29/2013US20130225589 Pyridopyrimidinone inhibitors of kinases
08/29/2013US20130225583 Substituted amino-triazolyl pde10 inhibitors
08/29/2013US20130225582 Biaryl-spiroaminooxzaoline analogues as alpha 2c adrenergic receptor modulators
08/29/2013US20130225577 Bicyclic diamines as janus kinase inhibitors
08/29/2013US20130225576 1h-pyrazolo[3,4-b]pyridines and therapeutic uses thereof
08/29/2013US20130225575 Methods for treating neurological conditions
08/29/2013US20130225567 5-Alkynyl Pyridine
08/29/2013US20130225561 Inhibitors of the renal outer medullary potassium channel
08/29/2013US20130225558 Fused tetracyclic pyrido [4,3-b] indole and pyrido [3,4-b] indole derivatives and methods of use
08/29/2013US20130225557 PYRIDO[3,2-d]PYRIMIDINE PI3K DELTA INHIBITOR COMPOUNDS AND METHODS OF USE
08/29/2013US20130225555 Imidazoquinolines with Immuno-Modulating Properties
08/29/2013US20130225554 New bicyclic compounds and their use as antibacterial agents and beta-lactamase inhibitors
08/29/2013US20130225553 Pyrazoloquinoline compound
08/29/2013US20130225552 Heterobicyclic compounds
08/29/2013US20130225551 Jak2 inhibitors and their use for the treatment of myeloproliferative diseases and cancer
08/29/2013US20130225549 Dihydropteridinones i
08/29/2013US20130225524 Chemical Compounds
08/29/2013US20130225411 Pesticidal compositions
08/29/2013US20130224186 Oxazole and thiazole compounds as ksp inhibitors
08/28/2013EP2631236A1 Substituted pyrazolo[1,5-a]pyridines, their preparation and use as medicaments
08/28/2013EP2630146A1 Crystaline (8s,9r)-5-fluoro-8-(4-fluorophenyl)-9-(1-methyl-1h-1,2,4-triazol-5-yl)-8,9-dihydro-2h-pyrido[4,3,2-de]phtalazin-3(7h)-one tosylate salt
08/28/2013EP2630140A1 Organic electroluminescent device
08/28/2013EP2630122A1 Arylamide derivatives as ttx-s blockers
08/28/2013EP2629616A2 Substituted amino-triazolyl pde10 inhibitors
08/28/2013CN1538951B Omega-aminoalkylamides of R-2-aryl-propionic acids as inhibitors of chemotaxis of polymorphonucleate and mononucleate cells
08/28/2013CN103270023A 4- { [ ( pyridin- 3 - Yl -methyl) aminocarbonyl] amino} benzene - sulfone derivatives as nampt inhibitors for therapy of diseases such as cancer
08/28/2013CN103265555A Tetracarboxylic acid perylene diimide compound, preparation method and application thereof
08/28/2013CN103265541A Synthesizing method of vinpocetine intermediate
08/28/2013CN103265480A Quinolinedione derivative, and preparation method and use thereof
08/28/2013CN102516244B Hexa-atomic aromatic heterocyclic imidazole mercapto-acetamide derivative, and preparation method and application thereof
08/28/2013CN102372709B Aryl phenanthroline compound and application thereof
08/28/2013CN102137860B Pyrimidines composition and method for preparing same
08/27/2013US8519142 Aryl pyridine as aldosterone synthase inhibitors
08/27/2013US8519135 Heteroaryl sulfonamides and CCR2/CCR9
08/27/2013US8518983 P38 inhibitors and methods of use thereof
08/27/2013US8518953 Aminopyrimidines useful as inhibitors of protein kinases
08/27/2013CA2649741C Biphenyl amide lactam derivatives as inhibitors of 11-beta-hydroxysteroid dehydrogenase 1
08/27/2013CA2599843C Selective glycosidase inhibitors, methods of making inhibitors, and uses thereof
08/27/2013CA2531868C Process for the preparation of thalidomide
08/22/2013WO2013123148A1 Inhibitors of human immunodeficiency virus replication
08/22/2013WO2013122953A1 Imidazolidine-2,4-dione derivatives as n-formyl peptide receptor 2 modulators
08/22/2013WO2013081400A3 Novel benzamide derivative and use thereof
08/22/2013US20130217878 (aza)indolizine derivative and pharmaceutical use thereof
08/22/2013US20130217720 Imidazolidine-2,4-dione derivatives as n-formyl peptide receptor 2 modulators
08/22/2013US20130217719 Combination of Organic Compounds
08/22/2013US20130217715 Derivatives of pyrazolophenyl-benzenesulfonamide compounds and use thereof as antitumor agents
08/22/2013US20130217705 Naphthyridine derivative
08/22/2013US20130217703 Sustituted 2,3,4,5-tetrahydro-1h-pyrido[4,3-b]indoles, methods for use thereof
08/22/2013US20130217690 Novel 3-hydroxyisothiazole 1-oxide derivatives
08/22/2013US20130217688 Heteroaryl compounds and uses thereof
08/22/2013US20130217684 Novel biaryl benzoimidazole derivatives and pharmaceutical composition comprising the same
08/22/2013US20130217680 Inhibitors of the Renal Outer Medullary Potassium Channel
08/22/2013US20130217675 Pyrido [4,3-b] indole and pyrido [3,4-b] indole derivatives and methods of use
08/22/2013US20130217672 (+)-3-hydroxymorphinan-based polycycle derivatives
08/22/2013US20130217671 Quinoline derivatives and melk inhibitors containing the same
08/22/2013US20130217668 Benzimidazole and azabenzimidazole compounds that inhibit anaplastic lymphoma kinase
08/22/2013US20130217664 Novel compounds useful for the treatment of degenerative and inflammatory diseases
08/22/2013US20130216498 Imidazopyridine derivatives as jak inhibitors
08/22/2013US20130216497 Novel tricyclic compounds
08/22/2013DE112012000221T5 Extrakte aus Cynanchum sp. Extracts of Cynanchum sp. und darin enthaltene Wirkstoffe zur Behandlung von Arthritis and active ingredients contained therein for the treatment of arthritis
08/21/2013EP2628727A2 Biaryl PDE4 inhibitors for treating pulmonary and cardiovascular disorders
08/21/2013EP2628726A1 Hydroxamate-based inhibitors of deacetylases b
08/21/2013EP2627655A2 Therapeutic 5,6,5-tricyclic analogs
08/21/2013EP2627654A1 Method of making azaindazole derivatives
08/21/2013EP2627648A1 17aHYDROXYLASE/C17,20-LYASE INHIBITORS
08/21/2013EP2543667A9 2-aminopyridine analogs as glucokinase activators
08/21/2013CN1533374B Substitutled cyclohexane-1,4-diamine derivatives
08/21/2013CN103261199A Naphthyridine derivative
08/21/2013CN103261198A 2-arylimidazo[1,2-]pyridazine, 2-phenylimidazo[1,2-a]pyridine, and 2-phenylimidazo[1,2-a]pyrazine derivatives
08/21/2013CN103261197A Highly-soluble pyrroloquinoline quinone salt and method for producing same
08/21/2013CN103261196A Pyrazolopyridines as inhibitors of the kinase lrrk2
08/21/2013CN103261195A 1,2,4-triazolo[4,3-]pyridine derivatives and their use as positive allosteric modulators of mglur2 receptors
08/21/2013CN103261170A Fused heterocyclic compound and use for pest control thereof
08/21/2013CN103261156A New compounds for the treatment of neurodegenerative diseases
08/21/2013CN103254191A Substituted aryl tetracyclic antifungal compound as well as preparation method and application thereof
08/21/2013CN103254190A Heteroaryl substituted pyrrolo[2,3-b]pyridines and pyrrolo[2,3-b]pyrimidines as janus kinase inhibitors
08/21/2013CN103254108A New preparation method of multifunctional pyrrole and pyrrolo [3, 4-C] quinoline
08/21/2013CN102311434B Evodiamine compounds, preparation method thereof and application thereof
08/21/2013CN102066359B Novel heteroaryl carboxamide derivatives
08/21/2013CN101941970B Meleimide derivatives, pharmaceutical compositions and methods for treatment of cancer
08/21/2013CN101861316B Imidazo[1,2-a]pyridine derivatives and their use as positive allosteric modulators of MGLUR2 receptors
08/21/2013CN101600714B Novel pyrindole kinase inhibitors
1 ... 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 ... 646